BioNTech SE - ADR vs Weibo Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: BioNTech SE - ADR is far larger — about 12.1× Weibo Corp's market cap, and Weibo Corp pays a 7.75% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | WB | |
|---|---|---|
Market Cap | $23.31B | $1.93B |
Sector | Health | Media |
52-Week High | $119.34 | $12.83 |
52-Week Low | $83.89 | $7.20 |
Enterprise Value | $6.60B | $1.20B |
Dividend Yield | — | 7.75% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →